Publications Office of the EU
2023/0304 - VENETOCLAX [100 MG; CÁP/ COMP] (V970) - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

2023/0304 - VENETOCLAX [100 MG; CÁP/ COMP] (V970)

Overview
  • Awarded
    06/05/2025
  • Today
    20/06/2025
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Unidade Local de Saúde Santa Maria, E.P.E.
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: Not available
Business sector (Main CPV)
33652000 Antineoplastic and immunomodulating agents
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
383,027.75 EUR
Procedure details
Tender reference number
251000136
Description

VENETOCLAX [100 MG; CÁP/ COMP]

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
Not available
Place of performance
PT1A0 Grande Lisboa
PT Portugal
CPV code

33652000 - Antineoplastic and immunomodulating agents

Award method
Criterion:
Type: price
Description: Preço
Weight (percentage, exact):
Estimated value
Not available
Final contracted value
383,027.75 EUR
Award of contract
Official name: ABBVIE, LDA
Postal address:
Town: AMADORA
Postal code: 2610-008
Country:
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.